Novavax
stock was climbing Tuesday after the company announced that an initial one million doses of its Covid-19 vaccine are now available for use in the U.K.
Shares of
Novavax
(ticker: NVAX) have struggled this year, tumbling 86% so far in 2022, and 90% in the past 12 months. The company slashed its full-year revenue guidance back in August, and posted a disappointing second quarter amid poor demand for its Covid-19 vaccine.
This text was written byObserveSearching for Alpha's transcripts crew is accountable for the event of all of our transcript-related initiatives....
GDP development recovered strongly within the third quarter of 2025, after the economic system contracted in the course of the...
Placing Rs 3 lakh into the market abruptly exposes your whole funding to present market traits. If the market occurs...
Brisbane: India's Abhishek Sharma completes a run through the fifth T20I cricket match of a sequence between India and Australia,...
ACI Worldwide has accomplished the acquisition of Cost Elements, a Greek-based fintech specialising in AI-driven monetary messaging and open banking...
Get the latest news and follow the coverage of Investing, World News, Stocks, Market Analysis, Business & Financial News, and more from the top trusted sources.
